What is true about immunization except: pneumococcal (Pneumococcal Conjugate Vaccine (PCV) and Pneumococcal Polysaccharide Vaccine (PPSV)) vaccine administration for individuals over 65 years, every 5 years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pneumococcal Vaccination in Adults Over 65: The False Statement

Statement A is FALSE: pneumococcal vaccine is NOT given every 5 years to adults over 65 years of age. According to the most recent 2023 ACIP guidelines, adults ≥65 years receive pneumococcal vaccination as a one-time series, not on a recurring 5-year schedule 1.

Current Pneumococcal Vaccination Recommendations for Adults ≥65 Years

Standard Approach (No Immunocompromising Conditions)

  • Adults ≥65 years with no prior pneumococcal vaccination should receive a single dose of PCV20 1, 2
  • If previously received PPSV23 only, give one dose of PCV20 at least 1 year after the last PPSV23 dose 1, 2
  • If previously received PCV13 only, give one dose of PCV20 at least 1 year after the PCV13 dose 1, 2
  • After PCV20 administration, no additional pneumococcal vaccines are needed 2

The 5-Year Interval Misconception

The confusion about "every 5 years" stems from older recommendations that are no longer current:

  • The 5-year interval only applies in specific scenarios where adults received both PCV13 and PPSV23 previously and are considering an additional PCV20 dose 1
  • This is NOT a routine revaccination schedule but rather a one-time consideration for those who completed the old two-vaccine series 1
  • Shared clinical decision-making is recommended for this scenario, and if PCV20 is given, it should be ≥5 years after the last pneumococcal vaccine dose 1

Special Populations: Immunocompromised Adults

For adults with immunocompromising conditions, CSF leak, or cochlear implant:

  • Give PCV15 followed by PPSV23 at ≥8 weeks (not 1 year) if using the two-vaccine approach 1
  • Alternatively, give a single dose of PCV20 1
  • Even in immunocompromised patients, this is NOT repeated every 5 years 1

Verification of Other Statements

Statement B: Hepatitis B - 3 Initial Doses

TRUE - The standard hepatitis B vaccination series consists of 3 doses given at 0,1, and 6 months (general medical knowledge).

Statement C: Varicella - 2 Doses at 0 and 4-8 Weeks

TRUE - Varicella vaccine for adults without evidence of immunity requires 2 doses separated by 4-8 weeks (general medical knowledge).

Statement D: Influenza Annually for Susceptible Individuals

TRUE - Annual influenza vaccination is recommended for all adults, particularly those at high risk (general medical knowledge).

Key Clinical Pitfalls to Avoid

  • Do not revaccinate adults ≥65 years with pneumococcal vaccine every 5 years - this is outdated practice 1
  • Once PCV20 is administered, the pneumococcal vaccination series is complete for most patients 2
  • The only scenario requiring consideration of additional vaccination is when both PCV13 and PPSV23 were previously given at age ≥65, and even then it requires shared decision-making, not automatic administration 1
  • Ensure at least 1 year has passed since the last PPSV23 dose before administering PCV20 in immunocompetent adults 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pneumococcal Conjugate Vaccine Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.